Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001209191-23-011665 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-22 | 2023-02-21 | VRTX | Arbuckle Stuart A | EVP, COO | S - Sale | $293.75 | -2,402 | 68.7K | -3% | -$705.6K |
| 2023-02-22 | 2023-02-17 | VRTX | Arbuckle Stuart A | EVP, COO | F - Tax | $292.85 | -4,498 | 71.1K | -6% | -$1.32M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-21 | S | D | 1,100 | $293.74 | 69,441 | D | — | — | (F4) Open market sales reported on this line occurred at a weighted average price of $293.74 (range $293.30 to $294.19). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-02-21 | S | D | 545 | $292.77 | 70,541 | D | — | — | (F3) Open market sales reported on this line occurred at a weighted average price of $292.77 (range $292.25 to $293.07). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-02-21 | S | D | 21 | $291.01 | 71,086 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-17 | F | D | 4,498 | $292.85 | 71,107 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-21 | S | D | 736 | $294.58 | 68,705 | D | — | — | (F5) Open market sales reported on this line occurred at a weighted average price of $294.58 (range $294.36 to $294.96). (F2) Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. |